Skip to main content
SpringerLink
Log in

Concomitant Cisplatin and Recombinant Interferon α-2b in Head and Neck Cancer

A Phase I Study

  • Short Communication
  • Published:
Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Carmichael J, Fergusson RJ, Wolf CR, Balkwill FR, Smyth JF. Augmentation of cytotoxicity of chemotherapy by human alpha-interferons in human non small cell lung cancer xenografts. Cancer Research 46: 4916–4920, 1986

    PubMed  CAS  Google Scholar 

  • Chirigos MA, Pearson JW. Cure of murine leukemia with drug and interferon treatment. Journal of the National Cancer Institute 51: 1367–1368, 1973

    PubMed  CAS  Google Scholar 

  • Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 47: 207–214, 1981

    Article  PubMed  CAS  Google Scholar 

  • Nardi M, Cognetti F, Pollera CF, Lombardi A, Atlante G, et al. Intraperitoneal recombinant alpha-2α-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study. Journal of Oncology 8: 1036–1041, 1990

    CAS  Google Scholar 

  • Vlock DR, Jonson J, Myers E, Day R, Gooding WE, et al. Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck. Head and Neck 13: 15–21, 1991

    Article  PubMed  CAS  Google Scholar 

  • Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, et al. Fluorouracil and recombinant alpha-2α-interferon: an active regimen against advanced colorectal carcinoma. Journal of Clinical Oncology 7: 1769–1775, 1989

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Oncologia Medica, Istituto Nazionale per la Ricerca sul Cancro (IST), Viale Benedetto XV, 10, 16132, Genoa, Italy

    Salvatore Toma, Marco Benasso, Marco Merlano, Enrico Albanese, Maria Pia Muttini & Riccardo Rosso

Authors
  1. Salvatore Toma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Benasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Merlano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Enrico Albanese
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Pia Muttini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Riccardo Rosso
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toma, S., Benasso, M., Merlano, M. et al. Concomitant Cisplatin and Recombinant Interferon α-2b in Head and Neck Cancer. Drug Invest. 3, 341–343 (1991). https://doi.org/10.1007/BF03259750

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259750

Keywords

Search

Navigation